| Publication Number | Title | Priority Date |
|---|---|---|
| CN-113480546-A | Preparation of Baricitinib and derivatives thereof | 2021-07-30 |
| CN-113582998-A | Preparation of 4- (1H-pyrazol-4-yl) -7H-pyrrolo [2,3-d ] pyrimidine | 2021-06-25 |
| CN-113336751-A | High-efficiency salt-induced kinase inhibitor and preparation method thereof | 2021-05-31 |
| CN-112500580-A | Preparation method and application of cobalt-based metal organic framework catalyst for activating oxygen molecules | 2020-11-30 |
| CZ-34975-U1 | Human constitutive adrostane receptor ligands | 2020-11-09 |
| CN-112538069-A | Azole derivative or pharmaceutically acceptable salt thereof, and preparation method and application thereof | 2020-11-05 |
| CN-112239469-B | Targeted protein degradation c-Met degradation agent and preparation method and application thereof | 2020-10-20 |
| CN-114181199-A | 2, 4-disubstituted pyrimidine derivative and preparation method and application thereof | 2020-09-15 |
| WO-2022051634-A1 | Quinoline cgas antagonist compounds | 2020-09-03 |
| WO-2022042691-A1 | Heterocyclic glp-1 agonists | 2020-08-28 |
